Dottikon ES Holding (DTI0) Stock Overview
Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for DTI0 from our risk checks.
DTI0 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Dottikon ES Holding AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 282.00 |
| 52 Week High | CHF 426.00 |
| 52 Week Low | CHF 282.00 |
| Beta | 1 |
| 1 Month Change | -7.84% |
| 3 Month Change | -21.67% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 1,794.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| DTI0 | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -4.1% | -2.0% | 0.1% |
| 1Y | n/a | 36.5% | -0.5% |
Return vs Industry: Insufficient data to determine how DTI0 performed against the German Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how DTI0 performed against the German Market.
Price Volatility
| DTI0 volatility | |
|---|---|
| DTI0 Average Weekly Movement | 7.5% |
| Pharmaceuticals Industry Average Movement | 6.2% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in DE Market | 12.7% |
| 10% least volatile stocks in DE Market | 2.7% |
Stable Share Price: DTI0 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: DTI0's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1913 | 900 | Markus Blocher | dottikon.com |
Dottikon ES Holding AG manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries. The company’s chemicals and intermediates include amines, anilines, azaindoles, benzimidazoles, benzoic acid derivatives, benzyl compounds, boron building blocks, chiral compounds, cyclohexane derivatives, cyclopropyl building blocks, indazoles, indoles, N-heterocycles, nitrate esters, nitroaromatic compounds, O-heterocycles, phenols and anisoles, and pyridine building blocks. It also offers Dottisol, a non-GMO isosorbide dimethyl ether for application as a solubility enhancer in cosmetic, pharma, and agro products, as well as a performance additive in various industries.
Dottikon ES Holding AG Fundamentals Summary
| DTI0 fundamental statistics | |
|---|---|
| Market cap | €3.91b |
| Earnings (TTM) | €111.47m |
| Revenue (TTM) | €473.36m |
Is DTI0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DTI0 income statement (TTM) | |
|---|---|
| Revenue | CHF 439.92m |
| Cost of Revenue | CHF 170.49m |
| Gross Profit | CHF 269.43m |
| Other Expenses | CHF 165.83m |
| Earnings | CHF 103.60m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
Nov 27, 2026
| Earnings per share (EPS) | 7.50 |
| Gross Margin | 61.25% |
| Net Profit Margin | 23.55% |
| Debt/Equity Ratio | 11.9% |
How did DTI0 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/23 23:31 |
| End of Day Share Price | 2026/07/23 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Dottikon ES Holding AG is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Tanya Hansalik | UBS Investment Bank |
| Daniel Jelovcan | Zürcher Kantonalbank |